XML 68 R58.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details)
$ in Thousands
1 Months Ended 3 Months Ended
Feb. 23, 2023
USD ($)
Jan. 31, 2022
USD ($)
Device
Jan. 31, 2022
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Lessee, Operating Lease, Description [Abstract]          
Extended lease term       5 years  
Increase in ROU asset and operating lease liability resulting from lease modification       $ 977 $ 0
Operating lease costs       106 106
Cash paid for amounts included in measurement of operating lease liabilities       $ 112 $ 96
Weighted average incremental borrowing rate       11.94%  
Weighted average remaining lease term       4 years 8 months 12 days  
Operating Lease Maturities [Abstract]          
Remaining 2024       $ 341  
2025       463  
2026       334  
2027       290  
2028       301  
Thereafter       231  
Total remaining lease payments       1,960  
Less: imputed interest       (494)  
Total lease liabilities       $ 1,466  
Milestone Payments [Abstract]          
Development agreement term       3 years  
Litigation Settlement [Abstract]          
Litigation settlement to be paid $ 106        
Litigation settlement accrued       $ 106  
TheraClear Corporation [Member]          
Milestone Payments [Abstract]          
Future earnout payment due upon revenue target   $ 1,000 $ 1,000    
Royalty and gross profit payments incurred       $ 66  
TheraClear Corporation [Member] | Foreign [Member]          
Milestone Payments [Abstract]          
Percentage of gross profit for future royalty payments for subsequent period     25.00%    
Subsequent period of gross profit for future royalty payments       4 years  
Tax Period from March 2014 through November 2022 [Member]          
Sales and Use Tax Matters [Abstract]          
Estimated tax positions subject to audit       $ 3,943  
Tax Period from March 2014 through November 2022 [Member] | Assessment One [Member]          
Sales and Use Tax Matters [Abstract]          
Assessment amount       1,484  
Tax Period from March 2014 through November 2022 [Member] | Assessment Two [Member]          
Sales and Use Tax Matters [Abstract]          
Assessment amount       1,273  
Tax Period From June 2018 Through June 2022 [Member]          
Sales and Use Tax Matters [Abstract]          
Estimated tax positions subject to audit       $ 1,186  
Minimum [Member]          
Lessee, Operating Lease, Description [Abstract]          
Remaining lease term       1 year  
Minimum [Member] | TheraClear Corporation [Member] | Domestic [Member]          
Milestone Payments [Abstract]          
Percentage of gross profit for future royalty payments for subsequent period     10.00%    
Maximum [Member]          
Lessee, Operating Lease, Description [Abstract]          
Remaining lease term       5 years  
Milestone Payments [Abstract]          
Future earnout payments   500 $ 500    
Future milestone payments   $ 3,000 3,000    
Number of devices in development | Device   3      
Maximum [Member] | Domestic [Member]          
Milestone Payments [Abstract]          
Future royalty payments   $ 500 500    
Maximum [Member] | TheraClear Corporation [Member]          
Milestone Payments [Abstract]          
Future earnout payments   3,000 3,000    
Future milestone payments   500 500    
Maximum [Member] | TheraClear Corporation [Member] | Domestic [Member]          
Milestone Payments [Abstract]          
Future royalty payments   $ 20,000 $ 20,000    
Percentage of gross profit for future royalty payments for subsequent period     20.00%